Table 1 Demographic and clinical data for 101 patients related to over-expression of heparanase based on IHC staining
From: Expression of heparanase in soft tissue sarcomas of adults
Characteristic | No. of patients out of entire group | No. of patients with over-expressed heparanase, according to sub-groups (%) | P value | |
|---|---|---|---|---|
Age | <40 | 21 | 6 (28.5%) | 0.65 |
40-59 | 21 | 11 (52.4%) | ||
60-69 | 30 | 16 (53.3%) | ||
>70 | 29 | 12 (43.3%) | ||
Gender | Male | 58 | 25 (43.1%) | 0.88 |
Female | 43 | 20 (46.5%) | ||
Pathological type | Malignant fibrous histiocytoma | 30 | 12 (40%) | 0.87 |
Liposarcoma | 16 | 8 (50%) | ||
Leiomyosarcoma | 13 | 6 (46.1%) | ||
Angiosarcoma | 4 | 1 (25%) | ||
Chondrosarcoma | 7 | 5 (71.4%) | ||
Sinovial sarcoma | 9 | 4 (44.4%) | ||
NOS | 22 | 9 (40.9%) | ||
Grade | Low | 28 | 12 (42.8%) | 0.44 |
Intermediate | 6 | 2 (33.3%) | ||
High | 67 | 31 (46.2%) | ||
Stage | I | 29 | 13 (44.8%) | 0.55 |
II | 7 | 1 (14.3%) | ||
III | 46 | 20 (43.4%) | ||
IV | 19 | 11 (57.9%) | ||
Total | 101 | 51 (50.5%) | ||